134 results
Page 5 of 7
8-K
EX-99.1
5buhf
10 Aug 20
Baudax Bio Reports Second Quarter 2020 Financial Results
7:01am
8-K
EX-99.2
yqy9m8g4xf
10 Aug 20
Baudax Bio Reports Second Quarter 2020 Financial Results
7:01am
8-K
EX-99.1
6vxjo roxkova
6 Aug 20
Baudax Bio Secures Permanent J-Code (J1738) for ANJESO® from
7:15am
8-K
30cyo8sizakmds0ex
6 Aug 20
Baudax Bio Secures Permanent J-Code (J1738) for ANJESO® from
7:15am
8-K
EX-99.1
oaqm vudx1y8t
20 Jul 20
Other Events
7:40am
8-K
EX-99.1
nii29u0qjvy9uz4
15 Jun 20
Baudax Bio Announces Full Commercial Launch of ANJESO™ and Receipt of UniqueC-Code and Pass-Through Payment Status
8:37am
8-K
umlrpp
15 Jun 20
Baudax Bio Announces Full Commercial Launch of ANJESO™ and Receipt of UniqueC-Code and Pass-Through Payment Status
8:37am
8-K
EX-10.1
bb5dk7v
2 Jun 20
Entry into a Material Definitive Agreement
7:45am
8-K
EX-10.2
lkpou
2 Jun 20
Entry into a Material Definitive Agreement
7:45am
424B5
r6x2det zfm
24 Mar 20
Prospectus supplement for primary offering
5:04pm
8-K
EX-1.1
udd1zuuru8z4qy9pva
24 Mar 20
Baudax Bio Announces Pricing of Public Offering of Common Stock and Warrants
9:33am
424B5
u2a vf9gq
23 Mar 20
Prospectus supplement for primary offering
5:27pm
8-K
EX-99.1
5iyp0x8c
21 Feb 20
Other Events
9:27am
8-K
EX-99.1
gada5k
20 Feb 20
Regulation FD Disclosure
5:29pm
8-K
EX-99.1
pg6ylcqj0ew5
14 Feb 20
Baudax Bio Reports 2019 Annual Financial Results
6:22am
424B5
lxeimx8vxg75q
13 Feb 20
Prospectus supplement for primary offering
5:30pm
10-K
EX-10.26
rzc34558z 4ge0b2o
13 Feb 20
Annual report
5:05pm
10-K
EX-10.29
j175o4nfoatwv
13 Feb 20
Annual report
5:05pm